| CPC A61K 31/575 (2013.01) [A61K 9/1658 (2013.01); A61K 31/22 (2013.01)] | 16 Claims |
|
1. A compound having a structure represented by Formula (I):
![]() or a pharmaceutically acceptable salt thereof,
wherein
A, a hydrophilic head, is selected from:
![]() wherein:
Ra and Ra′ are each independently selected from H, C1-C20 alkyl, C3-C20 cycloalkyl, C1-C20 heteroalkyl, C1-C20 heterocycloalkyl, C6 monocyclic aryl, and 5-8 monocyclic heteroaryl; and
Z is selected from a C1-C20 bivalent aliphatic radical and a C1-C20 bivalent heteroaliphatic radical;
B is
![]() wherein
R1 and R2 are each independently at each occurrence a C1-C20 bivalent aliphatic radical;
R3 and R4 are each independently at each occurrence selected from H and C1-C10 alkyl; or, alternatively, R3 and R4, together with the atom to which they are attached, form C3-C10 cycloalkyl;
R5 is independently at each occurrence selected from C1-C24 alkyl, C2-C24 alkenyl, C2-C24 alkynyl, C3-C24 cycloalkyl, C1-C24 heteroalkyl, C1-C24 heterocycloalkyl, aryl, and heteroaryl;
W is independently at each occurrence selected from O, S, and Se;
V is independently at each occurrence selected from a bond, O, S, and Se;
X is independently at each occurrence selected from
![]() wherein:
L1, L2, L3, and L4 are each independently at each occurrence selected from a bond, O, S, and NRc;
G is independently at each occurrence selected from O, S, and NRd;
Q is independently at each occurrence selected from ORf, SRg, and NRhRi;
r and t are each independently at each occurrence an integer from 1 to 6;
wherein Rc, Rd, Rf, Rg, Rh, and Ri are each independently at each occurrence selected from H, C1-C10 alkyl, C1-C10 heteroalkyl, aryl, and heteroaryl; and
m is 1; and
at least one of W and V is Se.
|